Fidelity Investments
CSBR icon

Fidelity Investments’s Champions Oncology CSBR Stock Holding History

Fidelity Investments’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Buy
+1
New +$6 ﹤0.01% 5538

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments's CSBR Position: Q2 2026 in Review

Fidelity Investments opened a new position in Champions Oncology (CSBR) in Q2 2026: 1 share worth $5. The stake represents ﹤0.01% of the portfolio and ranks #5538 among its holdings.

28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Fidelity Investments held 1 share of Champions Oncology worth $5 as of Q2 2026.
  • Champions Oncology was a new Fidelity Investments position in Q2 2026.
  • Champions Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5538 holding.
  • 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.